Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protara Therapeutics (TARA) Operating Expenses: 2013-2014

Historic Operating Expenses for Protara Therapeutics (TARA) over the last 2 years, with Dec 2014 value amounting to $10.5 million.

  • Protara Therapeutics' Operating Expenses was N/A to $3.3 million in Q4 2014 from the same period last year, while for Dec 2014 it was $10.5 million, marking a year-over-year change of. This contributed to the annual value of $10.5 million for FY2014, which is 47.82% up from last year.
  • Protara Therapeutics' Operating Expenses amounted to $10.5 million in FY2014, which was up 47.82% from $7.1 million recorded in FY2013.
  • Protara Therapeutics' 5-year Operating Expenses high stood at $10.5 million for FY2014, and its period low was $7.1 million during FY2013.
  • Over the past 2 years, Protara Therapeutics' median Operating Expenses value was $8.8 million (recorded in 2013), while the average stood at $8.8 million.
  • Data for Protara Therapeutics' Operating Expenses shows a peak YoY spiked of 47.82% (in 2014) over the last 5 years.
  • Protara Therapeutics' Operating Expenses (Yearly) stood at $7.1 million in 2013, then spiked by 47.82% to $10.5 million in 2014.